palmitoylethanolamide.com.au
HomeResearchFrikha 2025

Evaluation of N-palmitoylethanolamine (PEA) binding to nuclear receptors through docking and molecular dynamics studies

Frikha F, Aifa S. Comput Biol Med. 2025;184:109421.

Laboratory studyOther animals

Design
Laboratory study
Subjects
367 human nuclear receptor structures screened by computer
Dose used in the study
Not applicable
Duration
Not applicable
What was measured
Predicted binding of PEA to nuclear receptors, by molecular docking and dynamics simulation.

What the authors reported

The simulations ranked hepatocyte nuclear factor 4 (gamma and alpha) and retinoic acid receptor gamma as the strongest predicted binders. PPAR-alpha, the receptor most of the literature names as PEA's target, ranked 44th.

Limits of this study

A computer prediction with no laboratory or clinical test. It does not overturn the PPAR-alpha evidence from antagonist and knockout experiments, but it records that direct binding evidence is thinner than often stated, a point Rankin and Fowler 2020 also make. Authors declare no conflicts.

Source

PubMed 39561510 · doi:10.1016/j.compbiomed.2024.109421

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.